mots c and tirzepatide MOTS-c Peptide | Longevity & Metabolism MOTS-c: A promising mitochondrial-derived peptide

Tirzepatide is technically the combination of two different drugs: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Because of this, Tirzepatide is also known as a dual GLP-1/GIP receptor agonist. These are both hormones that your system releases after you eat

Any changes to your prescribed dosage must be managed by a licensed healthcare provider to ensure safety and efficacy

This information should be interpreted with a qualified healthcare provider to support more informed discussions about which mechanism may align with personal metabolic factors and tolerability expectationsnot to guarantee outcomes or replace clinical judgment

00:04:51 Vickie Danaher But the GLP-1 agonists for obesity have all been injectable up until now

In those cases, GLP-1 based therapies like tirzepatide and semaglutide offer clear advantages over SGLT2 inhibitors regarding urinary infection risk